PAZOPANIB
Manner of administration:Oral
Restriction (Streamlined authority code: 9247)
Indication: Advanced (unresectable and/or metastatic) soft tissue sarcoma
Treatment phase: Initial treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 90 | # of repeats: 2 | DPMQ: $1,318.99 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||